181 related articles for article (PubMed ID: 23554241)
1. Characterization of bone mineral-resembling biomaterials for optimizing human osteoclast differentiation and resorption.
Nakamura M; Hentunen T; Salonen J; Nagai A; Yamashita K
J Biomed Mater Res A; 2013 Nov; 101(11):3141-51. PubMed ID: 23554241
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement.
Rochet N; Balaguer T; Boukhechba F; Laugier JP; Quincey D; Goncalves S; Carle GF
Biomaterials; 2009 Sep; 30(26):4260-7. PubMed ID: 19481081
[TBL] [Abstract][Full Text] [Related]
3. The resorption of nanocrystalline calcium phosphates by osteoclast-like cells.
Detsch R; Hagmeyer D; Neumann M; Schaefer S; Vortkamp A; Wuelling M; Ziegler G; Epple M
Acta Biomater; 2010 Aug; 6(8):3223-33. PubMed ID: 20206720
[TBL] [Abstract][Full Text] [Related]
4. The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings.
Costa DO; Prowse PD; Chrones T; Sims SM; Hamilton DW; Rizkalla AS; Dixon SJ
Biomaterials; 2013 Oct; 34(30):7215-26. PubMed ID: 23830579
[TBL] [Abstract][Full Text] [Related]
5. The surface microporosity of ceramic biomaterials influences the resorption capacity of osteoclasts.
Zimmer G; Rohrhofer A; Lewis K; Goessl A; Hoffmann O
J Biomed Mater Res A; 2013 Dec; 101(12):3365-71. PubMed ID: 23553950
[TBL] [Abstract][Full Text] [Related]
6. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
[TBL] [Abstract][Full Text] [Related]
7. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.
Nakayama T; Mizoguchi T; Uehara S; Yamashita T; Kawahara I; Kobayashi Y; Moriyama Y; Kurihara S; Sahara N; Ozawa H; Udagawa N; Takahashi N
Bone; 2011 Dec; 49(6):1331-9. PubMed ID: 21983021
[TBL] [Abstract][Full Text] [Related]
8. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
[TBL] [Abstract][Full Text] [Related]
9. Formation of osteoclasts on calcium phosphate bone cements and polystyrene depends on monocyte isolation conditions.
Bernhardt A; Schumacher M; Gelinsky M
Tissue Eng Part C Methods; 2015 Feb; 21(2):160-70. PubMed ID: 24919531
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effect of hydrothermally synthesized biodegradable hydroxyapatite granules on osteogenesis and direct association with osteoclasts.
Gonda Y; Ioku K; Shibata Y; Okuda T; Kawachi G; Kamitakahara M; Murayama H; Hideshima K; Kamihira S; Yonezawa I; Kurosawa H; Ikeda T
Biomaterials; 2009 Sep; 30(26):4390-400. PubMed ID: 19481798
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of particulate bone substitute materials on the resorption activity of human osteoclasts.
Russmueller G; Winkler L; Lieber R; Seemann R; Pirklbauer K; Perisanidis C; Kapeller B; Spassova E; Halwax E; Poeschl WP; Macfelda K; Moser D
Eur Cell Mater; 2017 Oct; 34():291-306. PubMed ID: 29064533
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast adhesion and activity on synthetic hydroxyapatite, carbonated hydroxyapatite, and natural calcium carbonate: relationship to surface energies.
Redey SA; Razzouk S; Rey C; Bernache-Assollant D; Leroy G; Nardin M; Cournot G
J Biomed Mater Res; 1999 May; 45(2):140-7. PubMed ID: 10397968
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
14. Alendronate disturbs vesicular trafficking in osteoclasts.
Alakangas A; Selander K; Mulari M; Halleen J; Lehenkari P; Mönkkönen J; Salo J; Väänänen K
Calcif Tissue Int; 2002 Jan; 70(1):40-7. PubMed ID: 11907706
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
16. Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation.
Patntirapong S; Habibovic P; Hauschka PV
Biomaterials; 2009 Feb; 30(4):548-55. PubMed ID: 18996589
[TBL] [Abstract][Full Text] [Related]
17. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
Yaroslavskiy BB; Li Y; Ferguson DJ; Kalla SE; Oakley JI; Blair HC
J Cell Biochem; 2004 Apr; 91(5):962-72. PubMed ID: 15034931
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption.
Hsu CW; Olabisi RM; Olmsted-Davis EA; Davis AR; West JL
J Biomed Mater Res A; 2011 Jul; 98(1):53-62. PubMed ID: 21523904
[TBL] [Abstract][Full Text] [Related]
19. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
20. Influence of surface microstructure and chemistry on osteoinduction and osteoclastogenesis by biphasic calcium phosphate discs.
Davison NL; Su J; Yuan H; van den Beucken JJ; de Bruijn JD; Barrère-de Groot F
Eur Cell Mater; 2015 Jun; 29():314-29. PubMed ID: 26091730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
